// App-Quantinova.ai

: Mepolizumab self-administration via autoinjector and prefilled syringe: the qualitative patient experience

Researchers

Presenter

  • Lee Evitt

Principal Investigators

  • Richard Follows

  • Will Williams

  • Huda Shalhoub

  • Michael Celone

  • Shibing Yang

  • Robyn Von Maltzahn

Medical Centers

  • Value Evidence and Outcomes, GlaxoSmithKline, Brentford, United Kingdom,

  • GlaxoSmithKline, Uxbridge, United Kingdom

  • GlaxoSmithKline plc, Collegeville, United States of America

  • Evidera, Seattle, United States of America

  • Value Evidence & Outcomes, GSK, Collegeville, PA, United States,

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Recepteur d'Origine Nantais

Drug/Treatment

  • Mepolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT03099096

  • NCT03021304

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved